iBio (IBIO) Receivables - Other (2014 - 2024)
iBio (IBIO) posted quarterly Receivables - Other of $14.1 million for Q1 2024, up 176.55% year-over-year from $5.1 million in Q2 2023, and up 176.55% quarter-over-quarter from $5.1 million in Q1 2023.
iBio (IBIO) Receivables - Other (2014 - 2024) Analysis & Trends
iBio (IBIO) has reported Receivables - Other for 9 consecutive years, with $14.1 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Receivables - Other rose 176.55% year-over-year to $14.1 million; the TTM figure through Mar 2024 stood at $14.1 million (up 176.55% YoY), while the FY2023 annual figure was $204000.0, down 96.0% from the prior year.
- Receivables - Other improved to $14.1 million in Q1 2024 per IBIO's latest filing, from $5.1 million in the prior quarter.
- Across five years, Receivables - Other topped out at $14.1 million in Q1 2024 and bottomed at $1000.0 in Q1 2021.
- Historically, Receivables - Other has averaged $5.5 million across 5 years, with a median of $5.1 million in 2021.
- On a YoY basis, Receivables - Other climbed as much as 509900.0% in 2022 and fell as far as 0.0% in 2022.
- iBio's Receivables - Other stood at $52000.0 in 2020, then jumped by 9707.69% to $5.1 million in 2021, then changed by 0.0% to $5.1 million in 2022, then changed by 0.0% to $5.1 million in 2023, then surged by 176.55% to $14.1 million in 2024.
- Business Quant data shows IBIO's Receivables - Other at $14.1 million in Q1 2024, $5.1 million in Q1 2023, and $5.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | iBio | 178.20 Mn | 178.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 14.10 Mn |
| Mar 31, 2024 | 14.10 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 5.10 Mn |
| Sep 30, 2021 | 5.10 Mn |
| Jun 30, 2021 | 10.20 Mn |
| Jun 30, 2021 | 10.20 Mn |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Dec 31, 2020 | 52,000.00 |